Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C10H11FN2O |
| Molecular Weight | 194.2055 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=C(C=CC=C1F)[C@H]2COC(N)=N2
InChI
InChIKey=IOHOUWIYOVWGHV-SECBINFHSA-N
InChI=1S/C10H11FN2O/c1-6-7(3-2-4-8(6)11)9-5-14-10(12)13-9/h2-4,9H,5H2,1H3,(H2,12,13)/t9-/m1/s1
Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
RO-5263397
Created by
admin on Wed Apr 02 12:48:21 GMT 2025 , Edited by admin on Wed Apr 02 12:48:21 GMT 2025
|
PRIMARY | MedKoo CAT NO.: 522568, CAS NO.: 1357266-05-7Description: RO5263397 is a selective TAAR 1 agonist. RO5263397 was efficacious in reducing cocaine-mediated behaviors. RO5263397 dose-dependently prevented cocaine-induced lowering of ICSS thresholds. TAAR1 stimulation effectively suppresses the rewarding and reinforcing effects of cocaine in self-administration and ICSS models, supporting the candidacy of TAAR1 as a drug discovery target for cocaine addiction. (last updated: 1/6/2016). | ||
|
56835991
Created by
admin on Wed Apr 02 12:48:21 GMT 2025 , Edited by admin on Wed Apr 02 12:48:21 GMT 2025
|
PRIMARY | |||
|
Y2P4KD8GDR
Created by
admin on Wed Apr 02 12:48:21 GMT 2025 , Edited by admin on Wed Apr 02 12:48:21 GMT 2025
|
PRIMARY | |||
|
1357266-05-7
Created by
admin on Wed Apr 02 12:48:21 GMT 2025 , Edited by admin on Wed Apr 02 12:48:21 GMT 2025
|
PRIMARY | |||
|
300000042479
Created by
admin on Wed Apr 02 12:48:21 GMT 2025 , Edited by admin on Wed Apr 02 12:48:21 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
